MLAB Valuation

Mesa Laboratories Inc

Add to Watchlist

Advanced Chart

119.060

+3.660(+3.170%)

Overview
Forecast
Valuation

MLAB Relative Valuation

MLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MLAB is overvalued; if below, it's undervalued.

Historical Valuation

Mesa Laboratories Inc (MLAB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 15.68 is considered Undervalued compared with the five-year average of 32.21. The fair price of Mesa Laboratories Inc (MLAB) is between 163.70 to 344.67 according to relative valuation methord. Compared to the current price of 119.06 USD , Mesa Laboratories Inc is Undervalued By 27.27%.

Relative Value

Fair Zone

163.70-344.67

Current Price：119.06

27.27%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

4.04

P/B

Median3y

2.83

Median5y

3.15

6.87

FCF Yield

Median3y

5.03

Median5y

3.99

Competitors Valuation Multiple

The average P/S ratio for MLAB's competitors is 2.93, providing a benchmark for relative valuation. Mesa Laboratories Inc Corp (MLAB) exhibits a P/S ratio of 2.54, which is -13.45% above the industry average. Given its robust revenue growth of 17.52%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

MLAB.O

Mesa Laboratories Inc

2.54

Average P/S: 2.93

17.52%